{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:00:50Z","timestamp":1790082050417,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NHMRC Investigator Grant","award":["2022\/GNT2016380"],"award-info":[{"award-number":["2022\/GNT2016380"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10928-026-10060-9","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:50Z","timestamp":1790078630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A systems pharmacology model for paracetamol overdose and treatment"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-5768","authenticated-orcid":false,"given":"Jingyun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Chiew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey K.","family":"Isbister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Duffull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"10201","key":"10060_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s0140-6736(19)31894-x","volume":"394","author":"RT Stravitz","year":"2019","unstructured":"Stravitz RT, Lee WM (2019) Acute liver failure. Lancet (London England) 394(10201):869\u2013881. https:\/\/doi.org\/10.1016\/s0140-6736(19)31894-x","journal-title":"Lancet (London England)"},{"issue":"2","key":"10060_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/bcp.12802","volume":"81","author":"KL Hayward","year":"2016","unstructured":"Hayward KL, Powell EE, Irvine KM, Martin JH (2016) Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol 81(2):210\u2013222. https:\/\/doi.org\/10.1111\/bcp.12802","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10060_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000374090","volume":"33","author":"H Jaeschke","year":"2015","unstructured":"Jaeschke H (2015) Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients. Dig Dis 33(4):464\u2013471. https:\/\/doi.org\/10.1159\/000374090","journal-title":"Dig Dis"},{"issue":"6198","key":"10060_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/bmj.2.6198.1097","volume":"2","author":"LF Prescott","year":"1979","unstructured":"Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT (1979) Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ 2(6198):1097\u20131100. https:\/\/doi.org\/10.1136\/bmj.2.6198.1097","journal-title":"BMJ"},{"key":"10060_CR5","doi-asserted-by":"publisher","unstructured":"Chiew AL, Gluud C, Brok J, Buckley NA (2018) Interventions for paracetamol (acetaminophen) overdose. Cochrane Database of Systematic Reviews 2018 (2) (no pagination) (CD003328). https:\/\/doi.org\/10.1002\/14651858.CD003328.pub3","DOI":"10.1002\/14651858.CD003328.pub3"},{"issue":"2","key":"10060_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/15563650.2012.659252","volume":"50","author":"BH Rumack","year":"2012","unstructured":"Rumack BH, Bateman DN (2012) Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila) 50(2):91\u201398. https:\/\/doi.org\/10.3109\/15563650.2012.659252","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10060_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MJT.0b013e318250f829","volume":"20","author":"K Williamson","year":"2013","unstructured":"Williamson K, Wahl MS, Mycyk MB (2013) Direct comparison of 20-hour IV, 36-hour oral, and 72-hour oral acetylcysteine for treatment of acute acetaminophen poisoning. Am J Ther 20(1):37\u201340. https:\/\/doi.org\/10.1097\/MJT.0b013e318250f829","journal-title":"Am J Ther"},{"issue":"4","key":"10060_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0196-0644(00)70055-2","volume":"35","author":"OF Woo","year":"2000","unstructured":"Woo OF, Mueller PD, Olson KR, Anderson IB, Kim SY (2000) Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med 35(4):363\u2013368","journal-title":"Ann Emerg Med"},{"issue":"10","key":"10060_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/15563650.2017.1334915","volume":"55","author":"AL Chiew","year":"2017","unstructured":"Chiew AL, Isbister GK, Kirby KA, Page CB, Chan BSH, Buckley NA (2017) Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila) 55(10):1055\u20131065. https:\/\/doi.org\/10.1080\/15563650.2017.1334915","journal-title":"Clin Toxicol (Phila)"},{"issue":"9","key":"10060_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1080\/15563650.2018.1439950","volume":"56","author":"AL Chiew","year":"2018","unstructured":"Chiew AL, Isbister GK, Page CB, Kirby KA, Chan BSH, Buckley NA (2018) Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clin Toxicol (Phila) 56(9):810\u2013819. https:\/\/doi.org\/10.1080\/15563650.2018.1439950","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10060_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1445-5994.2009.02096.x","volume":"40","author":"A Graudins","year":"2010","unstructured":"Graudins A, Chiew A, Chan B (2010) Overdose with modified-release paracetamol results in delayed and prolonged absorption of paracetamol. Intern Med J 40(1):72\u201376. https:\/\/doi.org\/10.1111\/j.1445-5994.2009.02096.x","journal-title":"Intern Med J"},{"issue":"1","key":"10060_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/15563650.2017.1339887","volume":"56","author":"H Salmonson","year":"2018","unstructured":"Salmonson H, Sjoberg G, Brogren J (2018) The standard treatment protocol for paracetamol poisoning may be inadequate following overdose with modified release formulation: a pharmacokinetic and clinical analysis of 53 cases. Clin Toxicol (Phila) 56(1):63\u201368. https:\/\/doi.org\/10.1080\/15563650.2017.1339887","journal-title":"Clin Toxicol (Phila)"},{"key":"10060_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14642","author":"J Li","year":"2020","unstructured":"Li J, Chiew AL, Isbister GK, Duffull SB (2020) Sulfate conjugation may be the key to hepatotoxicity in paracetamol overdose. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.14642","journal-title":"Br J Clin Pharmacol"},{"issue":"19","key":"10060_CR14","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/0006-2952(81)90547-5","volume":"30","author":"JH Lin","year":"1981","unstructured":"Lin JH, Levy G (1981) Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats. Biochem Pharmacol 30(19):2723\u20132725","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"10060_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/jps.2600750910","volume":"75","author":"BK Wong","year":"1986","unstructured":"Wong BK, Galinsky RE, Corcoran GB (1986) Dissociation of increased sulfation from sulfate replenishment and hepatoprotection in acetaminophen-poisoned mice by N-acetylcysteine stereoisomers. J Pharm Sci 75(9):878\u2013880","journal-title":"J Pharm Sci"},{"issue":"19","key":"10060_CR16","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/0006-2952(79)90590-2","volume":"28","author":"AR Buckpitt","year":"1979","unstructured":"Buckpitt AR, Rollins DE, Mitchell JR (1979) Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation. Biochem Pharmacol 28(19):2941\u20132946. https:\/\/doi.org\/10.1016\/0006-2952(79)90590-2","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10060_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1172\/JCI110853","volume":"71","author":"BH Lauterburg","year":"1983","unstructured":"Lauterburg BH, Corcoran GB, Mitchell JR (1983) Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Investig 71(4):980\u2013991","journal-title":"J Clin Investig"},{"issue":"4","key":"10060_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/15563659809028022","volume":"36","author":"AL Jones","year":"1998","unstructured":"Jones AL (1998) Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol 36(4):277\u2013285","journal-title":"J Toxicol Clin Toxicol"},{"issue":"3","key":"10060_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1039\/b916458h","volume":"46","author":"H Shayani-Jam","year":"2010","unstructured":"Shayani-Jam H, Nematollahi D (2010) Electrochemical evidences in oxidation of acetaminophen in the presence of glutathione and N-acetylcysteine. Chem Commun (Camb) 46(3):409\u2013411. https:\/\/doi.org\/10.1039\/b916458h","journal-title":"Chem Commun (Camb)"},{"key":"10060_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fphar.2012.00204","volume":"3","author":"JG Diaz Ochoa","year":"2012","unstructured":"Diaz Ochoa JG, Bucher J, Pery AR, Zaldivar Comenges JM, Niklas J, Mauch K (2012) A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk. Front Pharmacol 3:204. https:\/\/doi.org\/10.3389\/fphar.2012.00204","journal-title":"Front Pharmacol"},{"issue":"2","key":"10060_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/hep.25656","volume":"56","author":"CH Remien","year":"2012","unstructured":"Remien CH, Adler FR, Waddoups L, Box TD, Sussman NL (2012) Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death. Hepatology (Baltimore MD) 56(2):727\u2013734. https:\/\/doi.org\/10.1002\/hep.25656","journal-title":"Hepatology (Baltimore MD)"},{"issue":"6","key":"10060_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/psp4.12298","volume":"7","author":"CL Mason","year":"2018","unstructured":"Mason CL, Leedale J, Tasoulis S, Jarman I, Antoine DJ, Webb SD (2018) Systems Toxicology Approach to Identifying Paracetamol Overdose. CPT Pharmacometrics Syst Pharmacol 7(6):394\u2013403. https:\/\/doi.org\/10.1002\/psp4.12298","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"1","key":"10060_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10928-020-09720-1","volume":"48","author":"J Li","year":"2021","unstructured":"Li J, Karlsson MO, Sanhajariya S, Isbister GK, Duffull SB (2021) A general model for cell death and biomarker release from injured tissues. J Pharmacokinet Pharmacodyn 48(1):69\u201382. https:\/\/doi.org\/10.1007\/s10928-020-09720-1","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"10060_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s13318-015-0253-x","volume":"41","author":"TJ Zurlinden","year":"2016","unstructured":"Zurlinden TJ, Reisfeld B (2016) Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach. Eur J Drug Metab Pharmacokinet 41(3):267\u2013280. https:\/\/doi.org\/10.1007\/s13318-015-0253-x","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"10060_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/bcp.12796","volume":"81","author":"TJ Zurlinden","year":"2016","unstructured":"Zurlinden TJ, Heard K, Reisfeld B (2016) A novel approach for estimating ingested dose associated with paracetamol overdose. Br J Clin Pharmacol 81(4):634\u2013645. https:\/\/doi.org\/10.1111\/bcp.12796","journal-title":"Br J Clin Pharmacol"},{"key":"10060_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1742-4682-9-55","volume":"9","author":"R Ben-Shachar","year":"2012","unstructured":"Ben-Shachar R, Chen Y, Luo S, Hartman C, Reed M, Nijhout HF (2012) The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model. Theor Biol Med Model 9:55. https:\/\/doi.org\/10.1186\/1742-4682-9-55","journal-title":"Theor Biol Med Model"},{"key":"10060_CR27","doi-asserted-by":"publisher","unstructured":"Li J, Chiew AL, Isbister GK, Duffull SB (2021) Population pharmacokinetics of immediate-release and modified-release paracetamol and its major metabolites in a supratherapeutic dosing study. Clin Toxicol 1\u20138. https:\/\/doi.org\/10.1080\/15563650.2021.1928163","DOI":"10.1080\/15563650.2021.1928163"},{"issue":"Suppl 2","key":"10060_CR28","first-page":"291s","volume":"10","author":"LF Prescott","year":"1980","unstructured":"Prescott LF (1980) Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol 10(Suppl 2):291s\u2013298s","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10060_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcph.24","volume":"53","author":"M Ganetsky","year":"2013","unstructured":"Ganetsky M, Bohlke M, Pereira L, Williams D, LeDuc B, Guatam S, Salhanick SD (2013) Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury. J Clin Pharmacol 53(4):413\u2013420. https:\/\/doi.org\/10.1002\/jcph.24","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10060_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1124\/jpet.117.242107","volume":"362","author":"MH Court","year":"2017","unstructured":"Court MH, Zhu Z, Masse G, Duan SX, James LP, Harmatz JS, Greenblatt DJ (2017) Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers. J Pharmacol Exp Ther 362(3):431\u2013440. https:\/\/doi.org\/10.1124\/jpet.117.242107","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10060_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1211\/0022357021779050","volume":"54","author":"H Itoh","year":"2002","unstructured":"Itoh H, Nagano T, Takeyama M (2002) Effect of nizatidine on paracetamol and its metabolites in human plasma. J Pharm Pharmacol 54(6):869\u2013873. https:\/\/doi.org\/10.1211\/0022357021779050","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10060_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/s0731-7085(03)00573-9","volume":"34","author":"LS Jensen","year":"2004","unstructured":"Jensen LS, Valentine J, Milne RW, Evans AM (2004) The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay. J Pharm Biomed Anal 34(3):585\u2013593. https:\/\/doi.org\/10.1016\/s0731-7085(03)00573-9","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"10060_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/FTD.0000000000000373","volume":"39","author":"LA Lammers","year":"2017","unstructured":"Lammers LA, Achterbergh R, Pistorius MC, Romijn JA, Mathot RA (2017) Quantitative Method for Simultaneous Analysis of Acetaminophen and 6 Metabolites. Ther Drug Monit 39(2):172\u2013179. https:\/\/doi.org\/10.1097\/FTD.0000000000000373","journal-title":"Ther Drug Monit"},{"issue":"5","key":"10060_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.2042-7158.2012.01459.x","volume":"64","author":"AM Rittau","year":"2012","unstructured":"Rittau AM, McLachlan AJ (2012) Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva sampling. J Pharm Pharmacol 64(5):705\u2013711. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01459.x","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10060_CR35","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/bcp.12644","volume":"80","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Harmatz JS, Epstein CR, Nakagawa Y, Kurosaki C, Nakamura T, Kadota T, Giesing D, Court MH, Greenblatt DJ (2015) Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen. Br J Clin Pharmacol 80(5):1076\u20131085. https:\/\/doi.org\/10.1111\/bcp.12644","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10060_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1742-6723.2010.01354.x","volume":"22","author":"A Chiew","year":"2010","unstructured":"Chiew A, Day P, Salonikas C, Naidoo D, Graudins A, Thomas R (2010) The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model. Emerg Med Australas 22(6):548\u2013555. https:\/\/doi.org\/10.1111\/j.1742-6723.2010.01354.x","journal-title":"Emerg Med Australas"},{"issue":"3","key":"10060_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jhep.2019.10.030","volume":"72","author":"AL Chiew","year":"2020","unstructured":"Chiew AL, James LP, Isbister GK, Pickering JW, McArdle K, Chan BSH, Buckley NA (2020) Early acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5). J Hepatol 72(3):450\u2013462. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.030","journal-title":"J Hepatol"},{"issue":"6","key":"10060_CR38","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/cpt.2888","volume":"113","author":"AL Chiew","year":"2023","unstructured":"Chiew AL, Isbister GK, Stathakis P, Isoardi KZ, Page C, Ress K, Chan BSH, Buckley NA (2023) Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose (ATOM-7). Clin Pharmacol Ther 113(6):1304\u20131314. https:\/\/doi.org\/10.1002\/cpt.2888","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10060_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00228-004-0862-9","volume":"60","author":"M Brown","year":"2004","unstructured":"Brown M, Bjorksten A, Medved I, McKenna M (2004) Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise. Eur J Clin Pharmacol 60(10):717\u2013723. https:\/\/doi.org\/10.1007\/s00228-004-0862-9","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10060_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/15563650.2019.1705971","volume":"58","author":"YK Li","year":"2020","unstructured":"Li YK, Lam KF, Wong CLW, Wong A (2020) In vitro study of pharmacobezoar formation in simulated acetaminophen overdose. Clin Toxicol (Phila) 58(9):900\u2013906. https:\/\/doi.org\/10.1080\/15563650.2019.1705971","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10060_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/03602532.2014.900565","volume":"46","author":"U Gundert-Remy","year":"2014","unstructured":"Gundert-Remy U, Bernauer U, Blomeke B, Doring B, Fabian E, Goebel C, Hessel S, Jackh C, Lampen A, Oesch F, Petzinger E, Volkel W, Roos PH (2014) Extrahepatic metabolism at the body\u2019s internal-external interfaces. Drug Metab Rev 46(3):291\u2013324. https:\/\/doi.org\/10.3109\/03602532.2014.900565","journal-title":"Drug Metab Rev"},{"issue":"3\u20134","key":"10060_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1081\/dmr-120000653","volume":"33","author":"MB Fisher","year":"2001","unstructured":"Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33(3\u20134):273\u2013297. https:\/\/doi.org\/10.1081\/dmr-120000653","journal-title":"Drug Metab Rev"},{"issue":"6","key":"10060_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jb\/mvv062","volume":"158","author":"A Yamamoto","year":"2015","unstructured":"Yamamoto A, Liu MY, Kurogi K, Sakakibara Y, Saeki Y, Suiko M, Liu MC (2015) Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. J BioChem 158(6):497\u2013504. https:\/\/doi.org\/10.1093\/jb\/mvv062","journal-title":"J BioChem"},{"issue":"6","key":"10060_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2125.1987.tb03107.x","volume":"23","author":"SM Rogers","year":"1987","unstructured":"Rogers SM, Back DJ, Stevenson PJ, Grimmer SF, Orme ML (1987) Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol. Br J Clin Pharmacol 23(6):721\u2013725. https:\/\/doi.org\/10.1111\/j.1365-2125.1987.tb03107.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10060_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00002018-199309010-00003","volume":"9","author":"GM Shenfield","year":"1993","unstructured":"Shenfield GM (1993) Oral contraceptives. Are drug interactions of clinical significance? Drug Saf 9(1):21\u201337. https:\/\/doi.org\/10.2165\/00002018-199309010-00003","journal-title":"Drug Saf"},{"issue":"2","key":"10060_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0031-6997(25)06846-2","volume":"47","author":"JN Commandeur","year":"1995","unstructured":"Commandeur JN, Stijntjes GJ, Vermeulen NP (1995) Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol Rev 47(2):271\u2013330","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10060_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1096\/fasebj.11.6.9194521","volume":"11","author":"CD Klaassen","year":"1997","unstructured":"Klaassen CD, Boles JW (1997) Sulfation and sulfotransferases 5: the importance of 3\u2019-phosphoadenosine 5\u2019-phosphosulfate (PAPS) in the regulation of sulfation. FASEB journal: official publication Federation Am Soc Experimental Biology 11(6):404\u2013418","journal-title":"FASEB journal: official publication Federation Am Soc Experimental Biology"},{"issue":"1\u20132","key":"10060_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mam.2008.08.004","volume":"30","author":"N Ballatori","year":"2009","unstructured":"Ballatori N, Krance SM, Marchan R, Hammond CL (2009) Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 30(1\u20132):13\u201328. https:\/\/doi.org\/10.1016\/j.mam.2008.08.004","journal-title":"Mol Aspects Med"},{"key":"10060_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-4682-5-8","volume":"5","author":"MC Reed","year":"2008","unstructured":"Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF (2008) A mathematical model of glutathione metabolism. Theor Biol Med Model 5:8. https:\/\/doi.org\/10.1186\/1742-4682-5-8","journal-title":"Theor Biol Med Model"},{"issue":"3","key":"10060_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jn\/122.3.420","volume":"122","author":"MH Stipanuk","year":"1992","unstructured":"Stipanuk MH, Coloso RM, Garcia RAG, Banks MF (1992) Cysteine Concentration Regulates Cysteine Metabolism to Glutathione, Sulfate and Taurine in Rat Hepatocytes. J Nutr 122(3):420\u2013427. https:\/\/doi.org\/10.1093\/jn\/122.3.420","journal-title":"J Nutr"},{"issue":"3","key":"10060_CR51","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0022-3565(25)11113-0","volume":"261","author":"H Kim","year":"1992","unstructured":"Kim H, Rozman P, Madhu C, Klaassen CD (1992) Homeostasis of sulfate and 3\u2019-phosphoadenosine 5\u2019-phosphosulfate in rats after acetaminophen administration. J Pharmacol Exp Ther 261(3):1015\u20131021","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10060_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/clpt.1987.50","volume":"41","author":"JT Slattery","year":"1987","unstructured":"Slattery JT, Wilson JM, Kalhorn TF, Nelson SD (1987) Dose-dependent pharmacokinetics of acetaminophen: Evidence of glutathione depletion in humans. Clin Pharmacol Ther 41(4):413\u2013418. https:\/\/doi.org\/10.1038\/clpt.1987.50","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10060_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0090-9556(25)07814-6","volume":"13","author":"J Hjelle","year":"1985","unstructured":"Hjelle J, Hazelton G, Klaassen C (1985) Acetaminophen decreases adenosine 3\u2019-phosphate 5\u2019-phosphosulfate and uridine diphosphoglucuronic acid in rat liver. Drug Metab Dispos 13(1):35\u201341","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10060_CR54","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0026-895X(25)12555-8","volume":"27","author":"KJ Hoffmann","year":"1985","unstructured":"Hoffmann KJ, Streeter AJ, Axworthy DB, Baillie TA (1985) Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol Pharmacol 27(5):566\u2013573","journal-title":"Mol Pharmacol"},{"key":"10060_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1555","author":"S Jiang","year":"2019","unstructured":"Jiang S, Madrasi K, Samant T, Lagishetty C, Vozmediano V, Chiew A, Abdel-Rahman SM, James LP, Schmidt S (2019) Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children. J Clin Pharmacol. https:\/\/doi.org\/10.1002\/jcph.1555","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10060_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00606662","volume":"31","author":"L Borgstrom","year":"1986","unstructured":"Borgstrom L, Kagedal B, Paulsen O (1986) Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 31(2):217\u2013222","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10060_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13(2):143\u2013151. https:\/\/doi.org\/10.1208\/s12248-011-9255-z","journal-title":"AAPS J"},{"issue":"3","key":"10060_CR58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/bf00558162","volume":"36","author":"LF Prescott","year":"1989","unstructured":"Prescott LF, Speirs GC, Critchley JA, Temple RM, Winney RJ (1989) Paracetamol disposition and metabolite kinetics in patients with chronic renal failure. Eur J Clin Pharmacol 36(3):291\u2013297. https:\/\/doi.org\/10.1007\/bf00558162","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10060_CR59","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2125.2010.03810.x","volume":"71","author":"DW Kim","year":"2011","unstructured":"Kim DW, Tan EY, Jin Y, Park S, Hayes M, Demirhan E, Schran H, Wang Y (2011) Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia. Br J Clin Pharmacol 71(2):199\u2013206. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03810.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10060_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1248\/bpb.30.157","volume":"30","author":"S Shinoda","year":"2007","unstructured":"Shinoda S, Aoyama T, Aoyama Y, Tomioka S, Matsumoto Y, Ohe Y (2007) Pharmacokinetics\/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain. Biol Pharm Bull 30(1):157\u2013161. https:\/\/doi.org\/10.1248\/bpb.30.157","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10060_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/bcp.15903","volume":"90","author":"LF Prescott","year":"2024","unstructured":"Prescott LF (2024) Paracetamol (acetaminophen) poisoning: The early years. Br J Clin Pharmacol 90(1):127\u2013134. https:\/\/doi.org\/10.1111\/bcp.15903","journal-title":"Br J Clin Pharmacol"},{"key":"10060_CR62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.apha.2019.01.007","volume":"85","author":"A Ramachandran","year":"2019","unstructured":"Ramachandran A, Jaeschke H (2019) Acetaminophen hepatotoxicity: A mitochondrial perspective. Adv Pharmacol 85:195\u2013219. https:\/\/doi.org\/10.1016\/bs.apha.2019.01.007","journal-title":"Adv Pharmacol"},{"issue":"8","key":"10060_CR63","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/15563650.2019.1579914","volume":"57","author":"RG Hendrickson","year":"2019","unstructured":"Hendrickson RG (2019) What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? Clin Toxicol (Phila) 57(8):686\u2013691. https:\/\/doi.org\/10.1080\/15563650.2019.1579914","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10060_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.aaen.2003.07.001","volume":"12","author":"RM Lynch","year":"2004","unstructured":"Lynch RM, Robertson R (2004) Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 12(1):10\u201315. https:\/\/doi.org\/10.1016\/j.aaen.2003.07.001","journal-title":"Accid Emerg Nurs"},{"issue":"5","key":"10060_CR65","first-page":"251","volume":"72","author":"A Koppen","year":"2014","unstructured":"Koppen A, van Riel A, de Vries I, Meulenbelt J (2014) Recommendations for the paracetamol treatment nomogram and side effects of N-acetylcysteine. Neth J Med 72(5):251\u2013257","journal-title":"Neth J Med"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10060-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:52Z","timestamp":1790078632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-026-10060-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10060"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10060-9","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"52"}}